文献速递青光眼

应用SOURCE眼科数据仓库对青光眼患者进行疫情期预约分诊

Application of the Sight Outcomes Research Collaborative Ophthalmology Data Repository for Triaging Patients With Glaucoma and Clinic Appointments During Pandemics Such as COVID-19.
PubMed 文献 · JAMA Ophthalmol · 2020-01-01

本研究基于SOURCE眼科电子健康记录数据仓库,开发了一种结合青光眼严重程度与进展风险评分和COVID-19 morbidity风险评分的分诊工具。在1034例青光眼预约患者中,采用不同总分阈值可识别需推迟预约的比例,并帮助在恢复期优先安排预约。

要点

  • 总分阈值0、25、50分别识别93.8%、64.6%、26.6%的预约可推迟。
  • 工具综合青光眼进展风险与COVID-19 morbidity风险。
  • 该方法可推广至其他眼科及非眼科护理的分诊。

核心结论

  • 开发并实施了一个考虑眼科疾病进展风险和COVID-19暴露morbidity风险的分诊工具,便于对即将到来的眼科预约进行分诊。

研究设计与样本

  • 横断面研究,纳入2020年3月16日至4月16日期间在SOURCE眼科电子健康记录数据仓库中一家学术机构有青光眼预约的患者1034例。

主要发现

  • 患者平均(SD)年龄66.7(14.6)岁,女性575例(55.6%),白人733例(71%),黑人160例(15.5%)。
  • 平均(SD)青光眼严重程度与进展风险评分为4.0(14.4)分,COVID-19 morbidity风险评分为27.2(16.1)分,总分为31.2(21.4)分。
  • 在疫情相关服务减少期间,总分阈值0、25、50分别识别970例(93.8%)、668例(64.6%)、275例(26.6%)预约需推迟和重新安排。

关键数值与推荐

  • 总分阈值0分识别93.8%的预约可推迟,25分识别64.6%,50分识别26.6%。

临床怎么用

  • 可用于疫情或类似危机期间,根据青光眼进展风险和COVID-19 morbidity风险对眼科预约进行分诊和优先重新安排。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: During the coronavirus disease 2019 (COVID-19) pandemic, eye care professionals caring for patients with sight-threatening diseases, such as glaucoma, have had to determine whether some patient appointments could safely get postponed, weighing the risk that the patient's glaucoma could worsen during the interim vs the morbidity risk of acquiring COVID-19 while seeking ophthalmic care. They also need to prioritize appointment rescheduling during the ramp-up phase (when pandemic-associated service reductions are eased). OBJECTIVE: To describe a flexible and scalable scoring algorithm for patients with glaucoma that considers glaucoma severity and progression risk vs the presence of high-risk features for morbidity from COVID-19, using information from a large data repository. DESIGN, SETTING, AND PARTICIPANTS: In this cross-sectional study, patients with upcoming clinic appointments for glaucoma from March 16, 2020, to April 16, 2020, at an academic institution enrolled in the Sight Outcomes Research Collaborative (SOURCE) Ophthalmology Electronic Health Record Data Repository were identified. A risk stratification tool was developed that calculated a glaucoma severity and progression risk score and a COVID-19 morbidity risk score. These scores were summed to determine a total score for each patient. MAIN OUTCOMES AND MEASURES: Total scores and percentages of clinic appointments recommended for rescheduling. RESULTS: Among the 1034 patients with upcoming clinic appointments for glaucoma, the mean (SD) age was 66.7 (14.6) years. There were 575 women (55.6%), 733 White individuals (71%), and 160 Black individuals (15.5%). The mean (SD) glaucoma severity and progression risk score was 4.0 (14.4) points, the mean (SD) COVID-19 morbidity risk score was 27.2 (16.1) points, and the mean (SD) total score was 31.2 (21.4) points. During pandemic-associated reductions in services, using total score thresholds of 0, 25, and 50 points would identify 970 appointments (93.8%), 668 appointments (64.6%), and 275 appointments (26.6%), respectively, for postponement and rescheduling. The algorithm-generated total scores also helped prioritize appointment rescheduling during the ramp-up phase. CONCLUSIONS AND RELEVANCE: A tool that considers the risk of underlying ophthalmic disease progression from delayed care receipt and the morbidity risk from COVID-19 exposure was developed and implemented, facilitating the triage of upcoming ophthalmic appointments. Comparable approaches for other ophthalmic and nonophthalmic care during the COVID-19 pandemic and similar crises may be created using this methodology.

来源:JAMA Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Bommakanti NK, Zhou Y, Ehrlich JR, et al. Application of the Sight Outcomes Research Collaborative Ophthalmology Data Repository for Triaging Patients With Glaucoma and Clinic Appointments During Pandemics Such as COVID-19. JAMA Ophthalmol. 2020. PMID: 32678424. doi:10.1001/jamaophthalmol.2020.2974

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。